How to Sell a Dental Practice to Private Equity: A 2026 Guide From a Dentist Who Did It
A dentist who sold his multi-location group to private equity in 2021 shares the exact dental practice sale process, realistic 2026 timelines, JV vs full buyout structures, and critical questions to ask before signing an LOI.
Key Takeaways
- How to sell a dental practice to private equity in one sentence: Prepare 12–24 months in advance by normalizing adjusted EBITDA, building strong associate coverage, running a competitive process, and prioritizing deal structure over headline multiple.
- Selling dental practice timeline: Typically 12–36 months total — preparation (3–12 months), marketing (2–4 months), due diligence (2–4 months), and close (30–90 days) — plus a 3–5 year post-close employment period.
- Three main dental practice PE deal structures: Full buyout (max cash, no upside), Joint Venture (JV) with rollover equity (second bite potential), and DSO parent holding company equity.
- 2026 valuation reality: Platform-ready multi-location groups often command 9–11x adjusted EBITDA; solo or smaller practices trade closer to 4–6x. Rollover equity in strong JV deals can deliver meaningful second-bite upside at recap.
- Contrarian truth: Dentists who maximize total wealth focus on DSO exit strategy, rollover equity terms, management fees, and post-close control — not just the highest number on the LOI.
If you’re researching how to sell a dental practice to private equity, you’re already ahead of most dentists. Most sellers jump in focused only on the sticker price and later regret it.
When I built and sold Afinia Dental Group to private equity in 2021, I had created Cincinnati’s largest dental group through 15+ years of work. We had multiple locations, solid associate coverage, documented systems, and a team that could operate without me chairside daily. I thought I was fully prepared. I was — mostly. But with hindsight (and after advising other dentists on their exits), I now see where the real money is won or lost in a dental practice PE acquisition.
The biggest mistake isn’t the financials — it’s informational. Too many dentists treat a PE-backed DSO offer like buying a car: they haggle the EBITDA multiple up a fraction and declare victory. Meanwhile, the deal structure (rollover equity percentage, earnouts, post-close employment terms, management fees, and recapitalization timeline) quietly decides whether you truly come out ahead.
This 2026 guide is written for dentists generating $1M–$10M+ in collections who are exploring a sale to a PE-backed DSO. You’ll get the complete dental practice sale process, realistic timelines, the three deal structures compared, and the exact questions most dentists forget to ask before signing a letter of intent (LOI).
What “Selling a Dental Practice to Private Equity” Actually Means (Dental Practice PE Acquisition Explained)
Private equity rarely buys individual dental practices outright. Instead, you sell to a PE-backed DSO (Dental Service Organization) that has already raised capital from a private equity firm to consolidate and scale practices.
This distinction is critical. In a typical dental practice PE acquisition, you’re joining a portfolio company with its own 3–7 year exit horizon. If you take rollover equity, you’re placing a bet on the DSO’s ability to grow and recapitalize at a higher multiple.
The dental M&A market in 2026 remains active but more selective than the 2021 peak. According to Large Practice Sales, approximately $8 billion was invested in independent DSOs in 2024, with transaction values ranging from 6.75x to 11.25x EBITDA for larger practices. Well-prepared practices with strong systems, associate benches, and clean financials still attract competitive offers. Platform groups continue to see stronger interest and higher adjusted EBITDA multiples than solo or heavily owner-dependent practices.
The Three Dental Practice PE Deal Structures (Comparison Table)
Most dentists fixate on the headline multiple. In reality, deal structure determines your actual take-home wealth far more than the initial EBITDA multiple.
Here’s a clear comparison of the three structures you’ll typically see in 2026:
- Conventional Full Buyout — Cash at Close: 70–90%. Retained Equity: None. Best for owners within 3 years of full retirement. Key trade-off: max immediate cash, zero future upside.
- Joint Venture (JV) with Rollover — Cash at Close: 51–80%. Retained Equity: 20–49% (often ~40%) at practice level. Best for mid-career dentists (40s–early 50s). Key trade-off: upside depends on DSO growth & recap timing.
- DSO Parent (HoldCo) Equity — Cash at Close: Varies. Retained Equity: Equity in the overall DSO/platform. Best for owners seeking broader portfolio exposure. Key trade-off: risk spread across entire DSO portfolio.
Conventional full buyout: Simplest option. You sell 100% and receive most cash at closing, with a portion held back or earned out over 2–3 years tied to performance and your post-close employment. No retained equity — you become an employee, not a partner.
Joint Venture (JV) with rollover equity: The most common sophisticated structure today. The DSO buys majority control (51–80%), you retain meaningful minority equity at the practice level. You continue receiving distributions and can cash out your rollover at the next recapitalization (often at 12–15x+), creating the famous “second bite of the apple.”
DSO parent equity: You roll into shares of the larger platform rather than your specific practice. This gives exposure to the entire DSO’s growth but also to its risks.
[ANDREW: VERIFY — the next paragraph states you used a JV with rollover at Afinia and that you would choose a JV again today. Confirm, edit, or replace with your actual preference before publishing.]
When I sold Afinia Dental Group, we used a joint venture structure with meaningful rollover equity. Today, with everything I’ve learned advising others, I would still lean toward a well-negotiated JV for most owners who aren’t retiring immediately — provided the DSO has a proven track record, strong leadership, and a realistic recap timeline. The potential second-bite upside usually outweighs the added complexity.
Choose based on your personal timeline and risk tolerance. A 58-year-old planning to wind down benefits from a full buyout. A 44-year-old who wants to keep producing and build more wealth often wins bigger with strong rollover equity in a solid JV.
Selling Dental Practice Timeline: How to Prepare 12–24 Months Before Going to Market
The highest-valued practices aren’t always the biggest — they’re the most “legible” to buyers. A buyer should clearly see stable revenue, systems, and a team that runs the business independently.
A disciplined selling dental practice timeline includes:
- Normalize your adjusted EBITDA — Add back owner compensation above market associate rates, remove personal expenses, and document everything. This is the number everything else is built on.
- Build strong associate coverage — Solo or owner-dependent practices face heavy key-person discounts. Multi-doctor groups with reliable associate production command significantly higher multiples. Per Focus Bankers’ 2026 benchmarks, solo GP practices typically trade at 3x–6x EBITDA while platform-ready multi-location groups command 9x–11x.
- Clean financials and quality of earnings readiness — Two years of clean, CPA-reviewed numbers reduce due diligence friction and support stronger offers.
- Legal and operational housekeeping — Review leases, associate contracts, equipment titles, and corporate structure early.
Start these steps 12–24 months before you want to go to market. Practices that prepare properly routinely outperform those that rush.
The Dental Practice Sale Process, Phase by Phase
A professional dental practice sale process to a PE-backed DSO usually spans 12–36 months from decision to cash in hand.
Phase 1: Preparation (3–12 months)
Normalize EBITDA, strengthen associate coverage, clean financials, fix legal items, and build your advisory team (broker, attorney, CPA with dental transaction experience).
Phase 2: Marketing & LOI Stage (2–4 months)
Your advisor creates a confidential information memorandum and shops to qualified buyers. You’ll receive multiple LOIs with varying multiples and structures. Model the full economics — not just the headline number.
Phase 3: Due Diligence & Negotiation (2–4 months)
Buyers dig deep into financials, clinical records, operations, and compliance. Clean preparation here prevents price reductions or deal killers.
Phase 4: Close & Transition (30–90 days)
Documents signed, funds wired, and your post-close employment begins. Most PE deals require 3–5 years of continued clinical commitment — negotiate these terms carefully.
DSO Exit Strategy: Questions Most Dentists Forget to Ask Before Signing an LOI
Before you sign any letter of intent, go beyond the multiple. These questions protect your DSO exit strategy:
- What is the DSO’s realistic recapitalization timeline and track record?
- Exactly what does the management fee (typically 5–9% of revenue) cover, and is it reasonable?
- What is the detailed plan for my team — staff retention, benefits, and culture changes?
- Who will be my actual day-to-day integration and operations contact after closing?
[ANDREW: VERIFY — the next paragraph attributes a specific question to your Afinia process. Confirm it’s accurate or replace with a real one before publishing.]
One question I was glad I asked during the Afinia process was: “How do you define and measure success for acquired practices in the first 12–24 months post-close?” The answer told me more about real incentives and pressure than any presentation ever could.
The Bottom Line
Selling a dental practice to private equity is likely the largest financial transaction of your career. The dentists who achieve the best outcomes aren’t necessarily the ones with the highest headline multiple — they’re the ones who deeply understood the deal structure, rollover equity implications, and post-close reality before signing.
If you’re thinking about an exit in the next 1–5 years, the best time to start preparing is now. Strong preparation built over years beats last-minute assembly every time.
Ready to evaluate where your practice stands and what a realistic 2026 exit could look like? Book a complimentary consultation. I’ve lived the process from the seller’s side and now help other dentists navigate it with eyes wide open.
Related reading: What DSO buyers actually look for · When to sell your dental practice · The hidden cost of operational chaos
Sources
- Large Practice Sales, “Quick Thoughts on 2024 Results & 2025 Practice Values,” January 2025.
- Dental Transitions, “Unpacking DSO Deal Structures.”
- Focus Bankers, “Dental Practice Valuation for 2026,” April 2026.
- Hemmens Associates, “Planning Your Dental Practice Sale Timeline,” November 2025.
Frequently Asked Questions About Selling a Dental Practice to Private Equity
How long does it take to sell a dental practice to private equity?
The full selling dental practice timeline is typically 12–36 months, plus a 3–5 year post-close employment commitment in most cases.
What multiples do PE-backed DSOs pay for dental practices in 2026?
Platform-ready multi-location groups often see 9–11x adjusted EBITDA. Add-on or smaller practices range from 4–8x depending on quality, associate coverage, and hygiene mix. Solo practices generally fall in the 4–6x range.
What is rollover equity in a dental practice PE acquisition?
Rollover equity is the percentage (often 20–49%) you retain in a JV structure. You can later liquidate it at the DSO’s next recap, frequently at a higher multiple — delivering the second bite of the apple.
Should I take all cash or rollover equity?
If you’re within ~3 years of full retirement, prioritize cash and shorter earnouts. Mid-career dentists who plan to stay productive often benefit more from a strong JV rollover equity position, assuming the DSO is well-managed.
Do I need a broker or advisor to sell to private equity?
For practices with meaningful EBITDA, a competitive sell-side process run by an experienced dental broker or investment banker almost always delivers better terms and leverage than going direct.
Will I have to keep working after the sale?
Yes — nearly all PE-backed DSO deals require 3–5 years of post-close clinical production. Negotiate hours, compensation, and non-compete terms aggressively, as they directly impact your lifestyle and after-tax results.
Andrew Killgore, D.M.D., F.A.G.D.
Dental business consultant, executive coach, and founder of Afinia Dental Group. Andrew helps dentists achieve business freedom through coaching, DSO strategy, and practice systemization.
About AndrewReady to Apply These Ideas?
Schedule a complimentary consultation with Andrew.
Book a Free Consultation